Ara-C Fever and Infections After High-Dose Ara-C Treatment in Pediatric Lymphoid Malignancies

Summary:The objective of this study was to examine the incidence and characteristics of Ara-C-related fever and the frequency and severity of infections after single-drug, high-dose Ara-C treatment (HDAC) in children treated for acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL). A ret